Atara Biotherapeutics
(NASDAQ) ATRA
Atara Biotherapeutics Financials at a Glance
Market Cap
$88.03M
Revenue (TTM)
$23.14M
Net Income (TTM)
-$9.47M
EPS (TTM)
-$0.88
P/E Ratio
-11.07
Dividend
$0.00
Beta (Volatility)
2.16 (High)
Dividend
$0.00
Beta (Volatility)
2.16 (High)
Price
$9.92
Volume
56,357
Open
$9.70
Price
$9.92
Volume
56,357
Open
$9.70
Previous Close
$9.86
Daily Range
$9.49 - $10.23
52-Week Range
$3.92 - $19.15
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
2.16 (High)
Price
$9.92
Volume
56,357
Open
$9.70
Previous Close
$9.86
Daily Range
$9.49 - $10.23
52-Week Range
$3.92 - $19.15
Estimated Earnings Date
Aug 10, 2026
ATRA News
![Biotech_Stocks_Step_1_Good_Data,_Step_2_Raise_Capital[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F605702%2Fbiotech_stocks_step_1_good_data_step_2_raise_capital1.jpg&w=3840&op=resize)
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Atara Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Anhco Nguyen, PhD
Website
www.atarabio.comHeadquarters
South San Francisco, CA 94080, US
ATRA Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
-27%
Net Income Margin
-41%
Return on Equity
0%
Return on Capital
-44%
Return on Assets
-47%
Earnings Yield
-9.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$88.03M
Shares Outstanding
9.01M
Volume
56.36K
Avg. Volume
1.41M
Financials (TTM)
Gross Profit
$99.56M
Operating Income
$35.86M
EBITDA
$38.63M
Operating Cash Flow
-$50.94M
Capital Expenditure
$0.00
Free Cash Flow
-$50.94M
Cash & ST Invst.
$8.48M
Total Debt
$52.80M
Atara Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$516.00K
-99.5%
Gross Profit
$392.00K
-99.5%
Gross Margin
75.97%
N/A
Market Cap
$88.03M
N/A
Market Cap/Employee
$575.36K
N/A
Employees
153
N/A
Net Income
-$4.15M
-110.9%
EBITDA
-$3.34M
-108.2%
Quarterly Fundamentals
Total Cash
$8.36M
-39.6%
Total Debt
$9.08M
-83.5%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$9.08M
-66.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-47.34%
N/A
Return on Invested Capital
-43.96%
N/A
Free Cash Flow
-$3.07M
+89.1%
Operating Cash Flow
-$3.07M
+89.1%